Cargando…

Impact of COVID-19 on Hepatocellular Carcinoma Management: A Multicountry and Region Study

PURPOSE: The COVID-19 pandemic has altered healthcare priorities which may adversely impact cancer management. We aimed to evaluate the impact of the pandemic on the diagnosis, treatment, and consultation methods for patients with hepatocellular carcinoma (HCC). PATIENTS AND METHODS: We conducted a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gandhi, Mihir, Ling, Wen-Huan, Chen, Chien-Hung, Lee, Joon Hyeok, Kudo, Masatoshi, Chanwat, Rawisak, Strasser, Simone I, Xu, Zhu, Lai, Soh-Han, Chow, Pierce Kah-Hoe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475812/ https://www.ncbi.nlm.nih.gov/pubmed/34589445 http://dx.doi.org/10.2147/JHC.S329018

Ejemplares similares

(11)C-Choline and FDG PET/CT Imaging of Primary Cholangiocarcinoma: A Comparative Analysis
por: Chotipanich, Chanisa, et al.
Publicado: (2015)

A Case of Well-differentiated Hepatocellular Carcinoma Identified on Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography
por: Huang, Hian Liang, et al.
Publicado: (2018)

Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: Its role in tumor progression and apoptosis
por: Huynh, Hung, et al.
Publicado: (2003)

VESPRO: An Individual Patient Data Prospective Meta-Analysis of Selective Internal Radiation Therapy Versus Sorafenib for Advanced, Locally Advanced, or Recurrent Hepatocellular Carcinoma of the SARAH and SIRveNIB Trials
por: Gebski, Val, et al.
Publicado: (2017)

A genomic enhancer signature associates with hepatocellular carcinoma prognosis
por: Jeon, Ah-Jung, et al.
Publicado: (2023)

Risk Factors of COVID-19 Critical Outcomes in the Eastern Mediterranean Region: Multicountry Retrospective Study
por: Lami, Faris, et al.
Publicado: (2022)

Validation study of a wellbeing scale (SPANE) in the Arab Gulf region: A multicountry study
por: Yaaqeib, Saad, et al.
Publicado: (2022)

Characteristics of patients with axial spondyloarthritis by geographic regions: PROOF multicountry observational study baseline results
por: Poddubnyy, Denis, et al.
Publicado: (2021)

Indicators of Family Care for Development for Use in Multicountry Surveys
por: Kariger, Patricia, et al.
Publicado: (2012)

Heat Wave and Mortality: A Multicountry, Multicommunity Study
por: Guo, Yuming, et al.
Publicado: (2017)

Three-Dimensional Aggregated Spheroid Model of Hepatocellular Carcinoma Using a 96-Pillar/Well Plate
por: Lee, Sang-Yun, et al.
Publicado: (2021)

Tumor‐adjacent tissue co‐expression profile analysis reveals pro‐oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma
por: Grinchuk, Oleg V., et al.
Publicado: (2017)

Systemic Therapy for Hepatocellular Carcinoma: Latest Advances
por: Kudo, Masatoshi
Publicado: (2018)

Durvalumab plus tremelimumab in unresectable hepatocellular carcinoma
por: Kudo, Masatoshi
Publicado: (2022)

Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region
por: Kim, Do Young, et al.
Publicado: (2023)

Temporal Variation in Heat–Mortality Associations: A Multicountry Study
por: Gasparrini, Antonio, et al.
Publicado: (2015)

Changes in Susceptibility to Heat During the Summer: A Multicountry Analysis
por: Gasparrini, Antonio, et al.
Publicado: (2016)

Lessons from a recent multicountry iatrogenic botulism outbreak
por: Anniballi, Fabrizio
Publicado: (2023)

Mpox in Children and Adolescents during Multicountry Outbreak, 2022–2023
por: Hoxha, Ana, et al.
Publicado: (2023)

Multicountry cholera outbreak alert in Kenya: Current efforts and recommendations
por: Anis, Heeba, et al.
Publicado: (2023)

The Acquired Vulnerability Caused by CDK4/6 Inhibition Promotes Drug Synergism Between Oxaliplatin and Palbociclib in Cholangiocarcinoma
por: Suppramote, Orawan, et al.
Publicado: (2022)

Targeted and immune therapies for hepatocellular carcinoma: Predictions for 2019 and beyond
por: Kudo, Masatoshi
Publicado: (2019)

Adjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinoma
por: Kudo, Masatoshi
Publicado: (2023)

Adjuvant Atezolizumab-Bevacizumab after Resection or Ablation for Hepatocellular Carcinoma
por: Kudo, Masatoshi
Publicado: (2023)

Comprehensive analysis of transcriptome profiles in hepatocellular carcinoma
por: Jin, Yu, et al.
Publicado: (2019)

New treatment paradigm with systemic therapy in intermediate-stage hepatocellular carcinoma
por: Kudo, Masatoshi
Publicado: (2022)

The Society for Immunotherapy of Cancer clinical practice guideline on immunotherapy for hepatocellular carcinoma
por: Kudo, Masatoshi
Publicado: (2023)

Surveillance, Diagnosis, and Treatment Outcome of Hepatocellular Carcinoma in Japan: 2023 Update
por: Kudo, Masatoshi
Publicado: (2023)

Multi-region sampling with paired sample sequencing analyses reveals sub-groups of patients with novel patient-specific dysregulation in Hepatocellular Carcinoma
por: Jeon, Ah-Jung, et al.
Publicado: (2023)

Over-prescription of short-acting β(2)-agonists and asthma management in the Gulf region: a multicountry observational study
por: Alzaabi, Ashraf, et al.
Publicado: (2022)

Infigratinib Mediates Vascular Normalization, Impairs Metastasis, and Improves Chemotherapy in Hepatocellular Carcinoma
por: Huynh, Hung, et al.
Publicado: (2019)

Selection of Systemic Treatment Regimen for Unresectable Hepatocellular Carcinoma: Does Etiology Matter?
por: Kudo, Masatoshi
Publicado: (2022)

Advances in Immunotherapy for Hepatocellular Carcinoma
por: Hagiwara, Satoru, et al.
Publicado: (2023)

Multicountry clinical outcomes of a new nondiffractive presbyopia-correcting IOL
por: Bala, Chandra, et al.
Publicado: (2022)

A multicountry measure of comovement and contagion in international markets: definition and applications
por: Tessler, Nina, et al.
Publicado: (2022)

Burden of hyperphagia and obesity in Bardet–Biedl syndrome: a multicountry survey
por: Forsythe, Elizabeth, et al.
Publicado: (2023)

Radiofrequency Ablation of Hepatocellular Carcinoma: A Literature Review
por: Minami, Yasunori, et al.
Publicado: (2011)

Changing the Treatment Paradigm for Hepatocellular Carcinoma Using Atezolizumab plus Bevacizumab Combination Therapy
por: Kudo, Masatoshi
Publicado: (2021)

Prioritized Requirements for First-Line Systemic Therapy for Hepatocellular Carcinoma: Broad Benefit with Less Toxicity
por: Kudo, Masatoshi
Publicado: (2023)

All Stages of Hepatocellular Carcinoma Patients Benefit from Systemic Therapy Combined with Locoregional Therapy
por: Kudo, Masatoshi
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eekt1jbd95g7ivbhhkai4ear1s